Metabolic syndrome as a clinical manifestation of endothelial dysfunction
https://doi.org/10.15829/1728-8800-2012-2-85-89
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Metabolic syndrome (MS) has recently gained more clinical attention due to its increasing prevalence and association with adverse prognosis. One of the main pathological features of MS is endothelial dysfunction. It plays a key role in the development of cardiovascular MS complications. Therefore, effective therapy aimed at the normalization of endothelial function should be a part of pathogenetic management of MS patients.
About the Authors
L. L. Kirichenko
Moscow State Medico-Stomatological University
Russian Federation
Russian Federation
K. V. Ovsyannikov
Moscow State Medico-Stomatological University
Russian Federation
Russian Federation
A. N. Fedoseev
Institute of Post-diploma Education, Russian Federal Medico-Biological Agency, City Clinical Hospital No. 36, Clinical Hospital No. 85, Moscow
Russian Federation
Russian Federation
A. M. Shklyarov
Moscow State Medico-Stomatological University
Russian Federation
Russian Federation
A. P. Korolev
Institute of Post-diploma Education, Russian Federal Medico-Biological Agency, City Clinical Hospital No. 36, Clinical Hospital No. 85, Moscow
Russian Federation
Russian Federation
References
1. Bubnova MG Obesity: the reasons and mechanisms of increase of weight of a body, approaches to correction. Cons med 2005; 7(5): 11-9. Russian (Bubnova M.G. Ozhirenie: prichiny i mekhanizmy narastaniya massy tela, podkhody k korrektsii. Cons med 2005; 7(5): 11-9.).
2. Kahn R, Buse J, Ferrannini E, Stern M The Metabolic Syndrome: Time for a Critical Appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.
3. Controlling the global obesity epidemic. World Health Organization. 2002; International Obesity Task Force. http://www.who.int/nut/obs.htm.
4. Obesity in Europe. The case far action. 2002; www.iotf.org.
5. Perova NV Hypolipidemichesky therapy at a metabolic syndrome. I international Scientific Forum of “Cardiology-99” 1999; 39-48. Russian (Perova N.V. Gipolipidemicheskaya terapiya pri metabolicheskom sindrome. I Mezhdunarodnyi Nauchnyi Forum “Kardiologiya-99” 1999; 39-48.).
6. Chazova IE, Mychka VB Obesity revealing. Cons med 2004; 04(1): 25-9. Russian (Chazova I.E., Mychka V.B. Vyyavlenie ozhireniya. Cons med 2004; 04(1): 25-9.).
7. Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J Intern Med 1991; 230: 195-201.
8. Kissebah AH, Evans DJ, Peiris A, Wilson CR Endocrine characteristics in regional obesities role of sex steroids. Excerpta Medica. Amsterdam 1985; 115-30.
9. Kissebah AH, Krakower GR Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811.
10. Pouliot MC, Desprès JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
11. Sinicina EN, Markovskij VB, Galanova AS, et al. Obesity and arterial hypertension. Att. Physician 2008; 2: 21-3. Russian (Sinitsina E.N., Markovskii V.B., Galanova A.S. i dr. Ozhirenie i arterial'naya gipertoniya. Lech vrach 2008; 2: 21-3.).
12. Astashkin EI, Glezer MG Obesity and arterial hypertension. Problems of female health 2008; 3 (4): 12-5. Russian (Astashkin E.I., Glezer M.G. Ozhirenie i arterial'naya gipertoniya. Probl zhen zdorov'ya 2008; 3 (4): 12-5.).
13. Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-71.
14. Wannamethee SG, Lowe GD, Rumley A, et al. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007; 30: 1200-5.
15. Chu NF, Spiegelman D, Hotamisligil GS, et al. Plasma insulin, leptin, and soluble TNF receptoirs levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atheroslerosis 2001; 157: 495-503.
16. Lu N, Boustany-Kari CM, Daugherty A, Cassis LA Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab 2007; 292: 1280-7.
17. Mancia G., Backer de G., Dominiczak A., et al. 2007 Guidelines for the mangement of arterial hypertension. Eur Heart J 2007; 28: 1462-536.
18. Asmar R., Zanchetti A. Guidelines for the use of self-blood pressure monitoring: a summary report of the first international consensus conference. J of Hypertens 2000; 18: 493-506.
19. Nevzorova VA, Pomogalova OG, Nastradin OV. Role endotelial dysfunctions in progressing of a metabolic syndrome from risk factors before vascular accidents. Pacific medical mag 2008; 3: 69-74. Russian (Nevzorova V.A., Pomogalova O.G., Nastradin O.V.. Rol' endotelial'noi disfunktsii v progressirovanii metabolicheskogo sindroma ot faktorov riska do sosudistykh katastrof. Tikhook med zh 2008; 3: 69-74.).
20. Liao D, Sloan RP, Cascio WE, et al. Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability. Diabetes Care 1998; 21: 2116-22.
21. Majanskaja SD, Kuimov AD Endotelial dysfunction and acute coronary syndrome. RCJ 2001; 2(28): 76-84. Russian (Mayanskaya S.D., Kuimov A.D. Endotelial'naya disfunktsiya i ostryi koronarnyi sindrom. Rossiiskii kardiologicheskii zhurnal 2001; 2(28): 76-84.).
22. Storozhakov GI, Verewagina GS, Malysheva NV Endotelial dysfunction at an arterial hypertension at patients of advanced age. Clin geront 2003; 9(1): 23-8. Russian (Storozhakov G.I., Vereshchagina G.S., Malysheva N.V. Endotelial'naya disfunktsiya pri arterial'noi gipertonii u patsientov pozhilogo vozrasta. Klin geront 2003; 9(1): 23-8.).
23. Lutaj MI Atherosclerosis: a modern view on pathogenesis. Ukr cardіol mag 2004; 1: 22-34. Russian (Lutai M.I. Ateroskleroz: sovremennyi vzglyad na patogenez. Ukr kardіol zh 2004; 1: 22-34.
24. Asmar J, Ruidavets JB, Charmontin B, et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19: 381-7.
25. Kobalava ZhD, Kotovskaja JuV, Markova MA, Villeval’de SV High systolic pressure: accent on elastic properties of arteries. Cardiovask ther profil 2006; 6(5): 10-6. Russian (Kobalava Zh.D., Kotovskaya Yu.V., Markova M.A., Villeval'de S.V. Vysokoe sistolicheskoe davlenie: aktsent na elasticheskie svoistva arterii. Kardiovaskulyarnaya terapiya i profilaktika 2006; 6(5): 10-6.).
26. Vasjuk JuA, Sadulaeva IA, Juwuk EN, et al. Metabolic syndrome: new aspects of an old problem. Arter hypert 2007; 13(2): 34-6. Russian (Vasyuk Yu.A., Sadulaeva I.A., Yushchuk E.N. i dr. Metabolicheskii sindrom: novye aspekty staroi problemy. Arter gipert 2007; 13(2): 34-6.)
Review
For citations:
Kirichenko L.L., Ovsyannikov K.V., Fedoseev A.N., Shklyarov A.M., Korolev A.P. Metabolic syndrome as a clinical manifestation of endothelial dysfunction. Cardiovascular Therapy and Prevention. 2012;11(2):85-89. (In Russ.) https://doi.org/10.15829/1728-8800-2012-2-85-89
Views:
786
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
